Benitec Biopharma Inc. SEC filings BNTC
Benitec Biopharma Inc. has 334 filings in SEC EDGAR's recent list, going back to Apr 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 14, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 20, 2026 | — |
| DEF 14A | Proxy statement | Oct 20, 2026 | Oct 20, 2026 |
| DEFA14A | Additional proxy material | Nov 12, 2025 | — |
| DEFA14A | Additional proxy material | Oct 14, 2025 | — |
| DEF 14A | Proxy statement | Oct 14, 2025 | Dec 1, 2025 |
| DEFA14A | Additional proxy material | Nov 14, 2024 | — |
| DEF 14A | Proxy statement | Oct 22, 2024 | Dec 4, 2024 |
| DEFA14A | Additional proxy material | Oct 22, 2024 | — |
| PRE 14A | Preliminary proxy statement | Oct 11, 2024 | Oct 11, 2024 |
| DEF 14A | Proxy statement | Jul 29, 2024 | Aug 29, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 19, 2024 | Jul 19, 2024 |
| DEFA14A | Additional proxy material | Oct 20, 2023 | — |
| DEF 14A | Proxy statement | Oct 20, 2023 | Dec 6, 2023 |
| DEFA14A | Additional proxy material | Oct 25, 2022 | — |
| DEF 14A | Proxy statement | Oct 25, 2022 | Dec 7, 2022 |
| PRE 14A | Preliminary proxy statement | Oct 14, 2022 | Oct 14, 2022 |
| DEF 14A | Proxy statement | Oct 22, 2021 | Dec 8, 2021 |
| PRE 14A | Preliminary proxy statement | Oct 12, 2021 | Oct 12, 2021 |
| DEF 14A | Proxy statement | Oct 22, 2020 | Dec 9, 2020 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BNTC (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Hayward, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1808898
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.